Nondipping in Parkinson's Disease
TL;DR: 24-hour blood pressure monitoring showed a high prevalence of nondipping in 40 patients with Parkinson's disease with and without orthostatic hypotension independent of coexisting arterial hypertension and antihypertensive treatment.
read more
Abstract: Objective. The aim of this study was to identify patients with Parkinson's disease who showed loss or decrease of nocturnal blood pressure fall (nondipper patients) as a marker of autonomic dysfunction. Presence or absence of orthostatic hypotension was considered to investigate whether alterations in circadian blood pressure pattern are associated with posture-related dysregulation of blood pressure. Methods. 40 patients with Parkinson's disease underwent 24-hour blood pressure monitoring. 21 patients were diagnosed with arterial hypertension and received anti-hypertensive drugs. Nondipper patients were defined as having nocturnal decrease of mean systolic and diastolic blood pressure less than 10%. Presence or absence of orthostatic hypotension was determined by Schellong's test. Results. We identified 35 nondipper patients (88%). Nondipping was detected in 20 patients with orthostatic hypotension (95%) and in 15 patients without orthostatic hypotension (79%). 18 patients with hypertensive and 22 patients with normal blood pressure values were detected. Conclusions. In conclusion 24-hour blood pressure monitoring showed a high prevalence of nondipping in 40 patients with Parkinson's disease with and without orthostatic hypotension independent of coexisting arterial hypertension and antihypertensive treatment. 24-hour blood pressure monitoring may be useful to identify non-dipping as a marker of autonomic dysfunction in patients with Parkinson's disease.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Kardiovaskuläre Störungen beim idiopathischen Parkinson-Syndrom
Wolfgang H. Jost
- 01 Dec 2017
TL;DR: Kardiovaskulare Symptome treten im klinischen Verlauf bei fast allen Patienten with einem Parkinson-Syndrom auf, und konnen in allen Phasen der Erkrankung beginnen und unterschiedliche Schweregrade aufweisen.
Nocturnal blood pressure changes in Parkinson's disease: correlation with autonomic dysfunction and vitamin D levels.
TL;DR: The number of patients with non-dipping and reverse dipping is high in PD, independent from PD severity, drug dose, vitamin D and the other NMS symptoms, and NMSQ scores are high in advanced PD.
Research progress of autonomic dysfunction in Parkinson's disease
Zhe ZHANG,Sheng-di CHEN +1 more
TL;DR: This review summarizes research on autonomic dysfunction in Parkinson's disease, covering epidemiology, clinical manifestations, treatment, and significance in early diagnosis and differential diagnosis, aiming to improve PD management.
Parkinson's disease between internal medicine and neurology
TL;DR: The various general medical aspects of Parkinson’s disease are discussed and its limitations, contraindications and interactions with dopaminergic substances have to be taken into consideration.
Cardiovascular/Stroke Risk Stratification in Parkinson’s Disease Patients Using Atherosclerosis Pathway and Artificial Intelligence Paradigm: A Systematic Review
Jasjit S. Suri,Sudip Paul,Mahesh A. Maindarkar,Anudeep Puvvula,Sanjay P. Saxena,Luca Saba,Monika Turk,John R. Laird,Narendra N. Khanna,Klaudija Višković,Inder M. Singh,Mannudeep K. Kalra,Padukode R. Krishnan,Amer M. Johri,Kosmas I. Paraskevas +14 more
TL;DR: The most fundamental cause of CVD/stroke damage due to PD is cardiac autonomic dysfunction due to neurodegeneration that leads to heart failure and its edema, and this validated the hypothesis and recommended strategies for removing the bias in AI for CVD-stroke risk prediction using the PD framework.
References
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
W R Gibb,Andrew J. Lees +1 more
TL;DR: Associated pathological findings suggest that cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease.
3.5K
Stages in the development of Parkinson’s disease-related pathology
TL;DR: Parkinsons disease is a multisystem disorder that involves only a few predisposed nerve cell types in specific regions of the human nervous system as discussed by the authors, where the intracerebral formation of abnormal proteinaceous Lewy bodies and Lewy neurites advances in a topographically predictable sequence.
2.4K
Molecular pathophysiology of parkinson's disease
TL;DR: Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD.
1.3K
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy
Irwin J. Schatz,R. Bannister,Roy Freeman,Christopher G. Goetz,Joseph Jankovic,Horacio Kaufmann,William C. Koller,Phillip A. Low,Christopher J. Mathias,R. J. Polinsky,Niall Quinn,D. Robertson,D. H.P. Streeten +12 more
1.2K
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy.
TL;DR: A Consensus Connce was convened on 16 November 1995 in Phoenix, Arizona, USA with the specific aim of generating a consensus on three specific items: the definition of orthostatic hypotension, pure autonomic failure (Bradbury Eggleston syndrome), and multiple system atrophy.
920